The spontaneous fibrinolytic activity of blood is due to a labile activator which appears to be stabilized by adsorption to fibrin (Fearnley and Tweed, 1953; Fearnley, 1953; Flute, 1960) . At present activator activity can be measured only indirectly through its conversion of plasminogen to plasmin which in turn causes fibrinolysis. Whatever method is used it is essential to cool the blood sample to 0°C. immediately it is obtained, and to carry out any subsequent manipulations at this temperature in order to preserve the activator which disappears rather rapidly from fluid blood kept at room temperature.
Two factors inhibit spontaneous fibrinolysis, the natural inhibitory capacity of the blood, which is probably complex, and the presence of calcium (Fearnley and Tweed, 1953; Fearnley and Lackner, 1955) . The first can be diminished by dilution as shown by MacFarlane (1937) or by separation of the euglobulin fraction, the inhibitors remaining in the supernatant. Calcium can be removed by precipitation. It is easier to measure fibrinolytic activity in blood than in plasma, and we have developed two simple methods for this purpose, one of which is really a modification of the other.
METHOD 1: DILUTE BLOOD CLOT LYSIS TIME This has been described by Fearnley, Balmforth, and Fearnley (1957 end-point when the lysis time is long, i.e., between 12 and 24 hours. As shown by Lackner and Goosen (1959) this can be overcome by photography. Figure 2 illustrates the photographic apparatus we use.1 Billimoria, Drysdale, James, and Maclagan (1959) have designed a modification of the dilute blood-clot lysis time test in which a number of tubes containing clots made from the same dilution of blood are incubated, and the haemoglobin loss is calculated at intervals of incubation. From this a curve is constructed and the 'half' lysis time calculated.
METHOD 2: THE FIBRINOLYTIC POTENTIAL
The method has already been described in this Journal by Chakrabarti and Fearnley (1962) .
Blood obtained by venepuncture is immediately cooled in melting ice. Blood, 5 ml., is diluted with an equal volume of ice-cold phosphate buffer, pH 7 4, M 0-12. (for preparation of buffer, see Fearnley et al., 1957) . Ten 1-90 ml. volume dilutions of blood in phosphate buffer are made in test-tubes standing in melting ice, the dilutions being such that the final concentration of blood in the test (volume 2-0 ml.) ranges from 5 to 27 5 %, the blood concentration interval between the tubes being 2 5 %. To each tube is added 0 1 ml. physiological saline containing 5 units of Parke Davis topical thrombin, each tube being shaken after thrombin has been added. After 15 minutes the tubes are placed in a waterbath at 37°C. Five to 10 minutes later each tube is briskly rotated between the palms of the hands to ensure freedom of retraction. The test is read after 12 hours' incubation, the highest concentration of blood to show complete lysis being the end-point. ' Made specially by Messrs. Shackman of Chesham, Bucks. This method depends on the fact that because of inhibition the more concentrated the suspension of blood the longer does lysis take. Consequently the greater the number of tubes showing lysis after 12 hours' incubation, the greater is the fibrinolytic activity of the blood sample. COMMENT It will be evident that both methods yield a crude overall picture of blood fibrinolytic activity. Each will be affected by activator level on the one hand and by inhibitor level on the other. The two methods correlate well, but the dilute blood clot lysis time test is the more sensitive.
We routinely use the dilute blood clot lysis time, and have found it to be a useful exploratory tool. It can be used to compare the blood fibrinolytic activity of individuals and to make daily determinations on patients. It reveals diurnal variability and the effects of stress and physical exercise. It is sensitive to the effects of drugs given to increase or diminish the spontaneous fibrinolytic activity of blood.
Nevertheless, in order to amplify information already obtained, exploration in depth seems desirable. The test does not reveal how far differences in fibrinolytic activity are related to activator or inhibitor levels, or to what extent the effects of testosterone, phenformin, and corticosteroids on blood fibrinolytic activity are mediated by changes in these parameters. By combining this test with the euglobulin lysis time on the one hand and with the plasmin inhibition test on the other it may prove possible to obtain such information.
